-
Costs, Expected Weight Loss Impact Bariatric Surgery Choice
drugs
December 25, 2018
For patients considering bariatric surgery, costs, expected weight loss, and resolution of medical conditions are the most important characteristics driving surgery decisions....
-
England's cost watchdogs nix Novartis' Kymriah for adults
fiercepharma
September 21, 2018
Novartis’ new CAR-T Kymriah drug only weeks ago picked up a blessing from England cost watchdogs to treat lymphoma in children. Now, the agency is turning away the drug in adult patients with relapsed or refractory ...
-
Treatment for MRSA no longer more costly than for susceptible Staph aureus infections
europeanpharmaceuticalreview
May 15, 2018
A new study found that infections caused by the drug resistant bacteria – methicillin-resistant Staphylococcus aureus, known as MRSA – are no more expensive to treat than MSSA, the methicillin-susceptible version of the same bacteria.
-
DH creates new role to streamline pharma costs
pharmatimes
July 28, 2017
The Department of Health has announced a new role to streamline commercial costs in the health and pharmaceutical sector: chief commercial officer.
-
Technology is key to improve R&D efficacy and cost effectiveness: Morgan Stanley report
financialexpress
April 17, 2017
It also highlights global tech companies’ investments to leverage opportunities arising through healthcare and technology convergence
-
Drug Importation 101
lilly
March 03, 2017
You may have heard the phrase “drug importation” as part of the ongoing debate over the cost of health care.